Part I: Testicular cancer—management of early disease
- 1 December 2003
- journal article
- Published by Elsevier in The Lancet Oncology
- Vol. 4 (12) , 730-737
- https://doi.org/10.1016/s1470-2045(03)01278-6
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- New directions in testicular cancer; molecular determinants of oncogenesis and treatment successEuropean Journal Of Cancer, 2003
- Effect of Graded Testicular Doses of Radiotherapy in Patients Treated for Carcinoma-In-Situ in the TestisJournal of Clinical Oncology, 2002
- Stage I non-seminomatous germ-cell tumours of the testis: identification of a subgroup of patients with a very low risk of relapseEuropean Journal Of Cancer, 2001
- Interdisciplinary consensus on diagnosis and treatment of testicular germ cell tumors: result of an update conference on evidence-based medicine (EBM).European Urology, 2001
- CarcinomaIn situ of the testis: Review of biological and clinical featuresInternational Journal of Cancer, 1999
- Prognostic risk factors that identify patients with clinical stage I nonseminomatous germ cell tumors at low risk and high risk for metastasisCancer, 1998
- Decrease in testosterone blood concentrations after testicular sperm extraction for intracytoplasmic sperm injection in azoospermic menThe Lancet, 1998
- CLINICAL STAGE I TESTIS CANCER: LONG-TERM OUTCOME OF PATIENTS ON SURVEILLANCEJournal of Urology, 1998
- International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers. International Germ Cell Cancer Collaborative Group.Journal of Clinical Oncology, 1997
- Medical Research Council prospective study of surveillance for stage I testicular teratoma. Medical Research Council Testicular Tumors Working Party.Journal of Clinical Oncology, 1992